Research project "armed forces institute for regenerative medicine."
Active Awarded Last action
- Contract number
- HT94252390022
- Awardee
-
Medical Technology Enterprise Consortium UEI RTGVVL7F6J11
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $57,810,043
Award facts
- Contract value 93% obligated
- $62,020,951.71 Current and potential, with all options
- Completion date 59% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Summerville, SC 29486, USA
- Primary consortia member
- Wake Forest University Health Sciences
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $62,072 | |
| Supplemental Agreement for work within scope | $2,485,181 | |
| Supplemental Agreement for work within scope | $3,485,984 | |
| Supplemental Agreement for work within scope | $3,252,832 | |
| Supplemental Agreement for work within scope | $9,926,290 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $38,597,684 |
Show all 13
About this award
The Defense Health Agency awarded an Other Transaction Order to Medical Technology Enterprise Consortium for the Armed Forces Institute for Regenerative Medicine research project on September 15, 2023, with a ceiling value of $57.8 million and ultimate completion date of December 23, 2028.
Place of performance is Summerville, SC. The research project supports prototype development and fielding of innovative regenerative medicine solutions for military healthcare applications. Medical Technology Enterprise Consortium operates as a nonprofit federal medical technology accelerator and prototype development platform under Other Transaction Authority, mobilizing academic and industry consortia members—including the University of Minnesota, University of Pittsburgh, and private sector partners such as Safi Biotherapeutics Inc. and OmniOx Inc.—to execute prototype development and experimental medical research. The organization competes full-and-open without small business set-asides and functions exclusively as a prime contractor, not as a subcontractor to other primes.
Quick answers
Who was awarded contract HT94252390022?
HT94252390022 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on September 15, 2023.
How much is contract HT94252390022 worth?
The government has obligated $57,810,043 on HT94252390022. Its current value, with exercised options, is $62,020,952.
Is contract HT94252390022 an order under another contract?
Yes. HT94252390022 is an other transaction order under W81XWH1590001, an other transaction IDV.
Was contract HT94252390022 competed?
The extent of competition for HT94252390022 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award